Why COG-UK is joining the UK Health Data Research Alliance
8 July 2021 | Author: Sharon Peacock, Executive Director and Chair at COG-UK, and a Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge.
Earlier this month, the COVID-19 Genomics UK (COG-UK) consortium joined the UK Health Data Research Alliance. By becoming a member of this growing partnership, COG-UK will achieve three important objectives: we will work with Health Data Research UK (HDR UK) and over 50 “Alliance” members, creating a unified approach to the use of health data across the UK; we will further support the UK’s response to COVID-19 by more widely sharing our expertise in genome sequencing; and we will be able to make our datasets securely available for researchers to request access via the Health Data Research Innovation Gateway (the Gateway).
Given that COG-UK was established in response to the COVID-19 pandemic in March 2020, and that the Alliance itself is only two years old, this is a great example of the incredible levels of collaboration that are so rapidly taking place across our sector.
And one of the most important lessons of the last 18 months is that collaboration is key. The incredible impact of health research in supporting the response to the pandemic has not been achieved by one organisation or in siloes. It has been a genuine success story for “Team Science”. By joining the Alliance, we’re committed to maintaining that approach.
The UK Health Data Research Alliance – collaboration in action
In its role as the national institute for health data science, HDR UK established the Alliance to be a driving force of this collaborative approach.
Bringing together multiple health research organisations, which are all using data at scale to share learnings and best practice, makes a huge amount sense. Ultimately, we all have the same motivation – to use the UK’s data assets in a trustworthy and secure way to develop discoveries that will benefit patients and save lives.
So, COG-UK is looking forward to working with other members to develop and coordinate the adoption of tools, techniques and technologies across five priority areas:
- Promoting participation across the sector and improving access to health data
- Aligning data standards and quality across the UK
- Agreeing approaches to Trusted Research Environments (TREs)
- Engaging practitioners, patients, and the public
- Supporting the development of the Gateway as the platform for researchers to request access to datasets
Sitting at the interface of public health action and academic research, COG-UK is committed to open science and sharing all data that we can as rapidly as possible, which aligns perfectly with the principles of open science encouraged by the UK Health Data Research Alliance.
Data linkage – a key component to advance research and understanding of COVID-19
Access to large-scale standalone datasets is of course important; but in some cases, this only tells one part of the story. The ability to link these datasets and perform analyses on them allows researchers to start piecing puzzles together – it increases the depth of research possible and, with genomic sequencing, allows researchers to understand more about the effects of different SARS-CoV-2 variants.
Since May, we have been working with HDR UK, the four UK Public Health Agencies and other data custodians to progress data linkages between important COVID-19-specific datasets and other routine health and administrative data (“The Research Data Linkage Group”), with viral genomic data from COG-UK identified as priority data for linkage due to its value in understanding COVID-19, and therefore potential to advise policy makers.
Linking viral genomic data with other routine data can help researchers answer the following critical questions:
- How do SARS-CoV-2 mutations impact on the severity of disease, the transmission of the disease, and the outcomes including risk of “Long COVID”?
- Is there any interaction between viral mutations and human genomics that influence severity and outcomes?
- How do different treatments work on different SARS-CoV-2 variants?
- How do different variants spread in different groups of people?
Working together, we have been able to securely transfer viral genomic data into TREs around the UK, where data can be stored safely and accessed by approved researchers. Once in these TREs, the data can then be linked to other routine health and administrative data, such as data from hospital care and demographic data, such as ethnicity, to answer these questions.
Improving coverage and access – a four nations approach
One of the distinguishing factors of HDR UK’s approach is that it works across all four nations of the UK, ensuring that our research and insights are not viewed in isolation.
Data about the different variants of UK SARS-CoV-2 found from English patients now flows into the Secure Research Service at the Office for National Statistics (ONS).
Data containing the full viral sequence of UK SARS-CoV-2 variants from English and Scottish patients will imminently flow into the Edinburgh Parallel Computing Centre (EPCC) at the University of Edinburgh. Also held within the EPCC is data from the ISARIC Coronavirus Clinical Characterisation Consortium (ISARIC 4C) which looks at what happens to patients with COVID-19 in hospital. Linking the ISARIC 4C data with the fully sequenced viral genomic data is crucial to understanding more about the effects of the different SARS-CoV-2 variants.
Viral genomic data from Welsh patients is securely stored in the SAIL databank, which is managed by the University of Swansea, and viral genomic data from Northern Irish patients is soon expected to flow into the Northern Ireland Honest Broker Service TRE.
As part of the Data and Connectivity National Core Study, researchers can request access to these anonymous and public datasets on UK SARS-CoV-2 viral genomic data, available via the Health Data Research Innovation Gateway.
Looking ahead, the ongoing generation of SARS-CoV-2 sequence data across the UK will continue to inform the response to this pandemic. Working with HDR UK will allow us to make more viral genomic data available to researchers, so that maximum benefit to public health can be derived from this important resource.
Request access to COG-UK datasets via the Gateway
Watch Sharon’s presentation from our HDR Scientific Conference
Executive Director and Chair at COG-UK, and a Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge. at University of Cambridge
Sharon Peacock CBE FMedSci is Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge. She is also Executive Director and Chair of the COVID-19...
Examining the DNA of the COVID-19 virus to find ways to tackle it (COG-UK project)
Examining the DNA sequence of the virus that causes COVID-19 will allow us to find ways to control the pathogen.